Apigenin
Flavonoid (flavone).
Bottom line
Apigenin is a flavone found in chamomile, parsley and celery [1]. As of November 11, 2026, we found no randomized trials of isolated apigenin on sleep (PubMed and Europe PMC search). Small chamomile trials found better self-rated sleep quality but no longer sleep [5][6]. Side effects were mostly mild, but allergic reactions, including anaphylaxis, have been reported [17][20].
- As of November 11, 2026, we found no randomized trials of isolated apigenin on sleep, mood or anxiety in people; human outcome trials used chamomile extract or tea (PubMed and Europe PMC search, November 11, 2026).
- In a 2024 meta-analysis of trials in healthy and diseased adults, chamomile improved self-rated sleep quality by 1.88 points on the Pittsburgh scale, with very high heterogeneity across 5 trials [5].
- The same review found chamomile did not lengthen sleep or improve sleep efficiency [5].
- Taken by mouth on its own, apigenin was poorly absorbed in healthy men, with 0.5% of the intake recovered in urine [4].
- In a review of 72 chamomile trials, reported side effects were mostly mild gastrointestinal complaints and drowsiness, while case reports describe allergic reactions [17].
Evidence by outcome
| Outcome | Grade | Basis | Modifiers | Rationale |
|---|---|---|---|---|
| Sleep latency | C Limited, no effect found | Small trials with mixed results; the only double-blind placebo-controlled trial cited (34 adults, clinical) was null on diary sleep latency | Subjective outcome only | Why C grade for Sleep latency: explainedApproved of the Sleep latency grade |
| Sleep quality | C Limited | Pooled estimates mix healthy and clinical populations with no healthy-only estimate; evidence is for chamomile extract or tea, not isolated apigenin | Subjective outcome onlyShort-term only | Why C grade for Sleep quality: explainedApproved of the Sleep quality grade |
| Calmness | C Limited, no effect found | A state-anxiety meta-analysis of 3 RCTs was null; the placebo-controlled positive trials are in diagnosed generalized anxiety disorder, and a 2024 review counted 9 of 10 trials positive without pooling; C with direction none | Subjective outcome only | Why C grade for Calmness: explainedApproved of the Calmness grade |
| Total sleep time | C Limited, no effect found | A meta-analysis in mixed populations found no improvement in sleep duration and one small clinical RCT was null; N needs adequate healthy-population RCTs | Subjective outcome only | Why C grade for Total sleep time: explainedApproved of the Total sleep time grade |
Grades describe evidence for each outcome, not a recommendation. Open a grade for its rationale and dated grade history. How we grade
Every graded outcome below rests on chamomile extract or tea, not isolated apigenin. Each study's form is named in the text. Grades follow our evidence grading method, and the outcomes belong to the sleep and mood and stress goals.
Does chamomile improve sleep quality?
A 2024 systematic review included 10 clinical trials (772 participants) of chamomile in healthy or diseased adults [5]. Pooling 5 trials, chamomile reduced Pittsburgh Sleep Quality Index (PSQI) scores, where lower is better, by 1.88 points compared with control (95% CI -3.46 to -0.31), with very high heterogeneity (I2 88.4%) [5]. Awakenings or staying asleep improved in 2 of 3 studies, but daytime functioning did not change in any of the 3 that measured it [5]. Only one included study checked blinding and tested the purity or potency of its product [5].
A 2019 meta-analysis of 12 randomized and quasi-randomized trials also found better sleep quality after chamomile (standardized mean difference -0.73, 95% CI -1.23 to -0.23) [6]. Its summary does not say how many trials or which populations this estimate pooled, and some trials may overlap with the 2024 review. Its authors called for larger trials [6].
The individual trials are small. In 60 adults aged 60 or over at a nursing-home day-care center in Iran, chamomile extract capsules (200 mg twice daily for 28 days) improved PSQI scores compared with wheat-flour capsules in a single-blind trial [8]. In 80 postnatal women with poor sleep in Taiwan, assigned systematically with a random start rather than fully at random, 2 weeks of chamomile tea lowered one sleep subscale, physical-symptom sleep inefficiency, compared with usual care, with no placebo, and the groups no longer differed at the 4-week follow-up [9]. In a double-blind pilot of 34 adults with chronic insomnia (a clinical population), the trial found no significant difference between chamomile extract and placebo in diary sleep quality [7]. That trial used tablets provided by the manufacturer, MediHerb [7]. Results from older adults, postnatal women and clinical groups may not apply to healthy adults.
Does chamomile help you fall asleep faster?
The time it takes to fall asleep is called sleep latency. Among the trials cited here, the only double-blind, placebo-controlled one that measured it was the 34-person insomnia pilot, which gave 270 mg of chamomile extract twice daily for 28 days [7]. It found no significant difference from placebo in diary sleep latency, although the effect size for latency favored chamomile [7]. The study tablets were provided by the manufacturer, MediHerb [7].
The 2024 review reported that sleep onset latency or ease of getting to sleep improved in 3 of 4 studies, but it did not pool them [5]. Evidence is mixed, because the studies are few, small and differ in product, population and blinding. NCCIH says there is very little information on chamomile in people with insomnia, a clinical population [20].
Does chamomile increase total sleep time?
The 2024 meta-analysis concluded that chamomile did not improve the duration of sleep or sleep efficiency [5]. Sleep efficiency did not change in 2 studies and got worse in 1 [5]. In the insomnia pilot, which used tablets provided by the manufacturer, MediHerb, total sleep time did not differ significantly between groups, and its effect size favored placebo [7]. The review authors call for future studies to use objective sleep measures [5].
Does chamomile affect calm and anxiety ratings?
For state anxiety, the pooled evidence is null. The 2019 meta-analysis pooled 3 randomized trials of state anxiety and found no difference from control (standardized mean difference -0.15, 95% CI -0.46 to 0.16) [6]. Its summary does not say who took part in those trials.
The clearest positive results come from placebo-controlled trials in adults with diagnosed generalized anxiety disorder, a clinical population. In an 8-week trial, 57 outpatients with mild to moderate symptoms were randomized to chamomile extract standardized to 1.2% apigenin or placebo, and Hamilton Anxiety Rating scores fell more with chamomile (P = 0.047) [10]. The authors wrote that chamomile may have modest anti-anxiety activity in people with mild to moderate generalized anxiety disorder [10]. In a longer trial, 179 adults took 1500 mg a day of a chamomile extract for 12 weeks, and the 93 responders were then randomized to continue chamomile or switch to placebo for 26 weeks [11]. The primary outcome, time to relapse, did not differ significantly (hazard ratio 0.52, 95% CI 0.20-1.33), though symptom scores stayed lower with chamomile (P = 0.0032) [11]. That extract was provided by the Swedish Herbal Institute, and the trial was funded by NIH [11].
A 2024 systematic review of 10 trials of oral chamomile found that 9 concluded it reduced anxiety, without pooling results, and said the mechanism is not well understood [12]. That review covered mixed populations, and the positive trials above were in clinical groups, so these results may not apply to healthy adults.
What the evidence does not show
As of November 11, 2026, we found no randomized trials of isolated apigenin on sleep, mood or anxiety in people (PubMed and Europe PMC search, November 11, 2026). The human studies that measured apigenin directly were absorption and food studies using pure apigenin, chamomile tea and parsley [4][14][15]; the one randomized trial that gave apigenin tested it in a combination (below). A 2024 review by two Tally Health employees reports that dietary apigenin intake correlated with sleep quality in a large cohort, which is an observational link and cannot show cause [13]. A 2006 review found no clinical trials of chamomile tea's sedative properties at that time [2].
One randomized, double-blind, placebo-controlled trial in 103 healthy, physically active adults gave an evening combination of 2 g magnesium L-threonate, 200 mg L-theanine and 50 mg apigenin for 2 weeks [19]. The evening combination did not differ from placebo on perceived stress (P = 0.684) or reported sleep disturbance (P = 0.478), and wearable measures of total sleep time and sleep efficiency showed no group effects [19]. The authors credited the improvements they found to a separate morning blend of ashwagandha and rhodiola [19]. The trial was funded by Momentous LLC, which made the study products [19]. As of November 12, 2026, we found no trials of apigenin combined with melatonin or glycine in people (PubMed search, November 12, 2026); the other magnesium combination data come from mice [18].
Doses used in studies
Ranges researchers used, not dosing advice. Bars share one scale. Read our disclaimer.
chamomile tea daily (amount per day not given in the abstract)
Timing and form
Form changes how much apigenin reaches the blood. In healthy men, apigenin from chamomile tea peaked at about 2 h, consistent with absorption in the upper gut, while a parsley drink peaked at 4 h [4]. In a parsley trial in 18 healthy volunteers, plasma apigenin could not be measured [15].
Studies standardized their chamomile products differently. One trial used an extract standardized to 1.2% apigenin [10], another a 500 mg extract with 6 mg of apigenin-7-glycosides per capsule [11], and the insomnia pilot reported 3.9 mg of apigenin per 90 mg of its extract [7]. The 2024 review notes that only one study tested the purity or potency of its product [5]. None of the studies cited here compared bedtime with daytime dosing.
What it is
Apigenin is a natural flavone, one of the flavonoids, found in plants such as celery, parsley and chamomile, where it occurs mostly bound to sugars as glycosides [1]. The human research on this page used chamomile, which NCCIH lists as German chamomile, Latin names Matricaria recutita and Matricaria chamomilla [20]. Its flowers contain several flavonoids, mainly apigenin, quercetin, patuletin and luteolin, and an essential oil rich in alpha-bisabolol and chamazulene [2]. A chamomile product therefore delivers many compounds besides apigenin.
Mechanism, from laboratory and animal work: in a 1995 study, apigenin isolated from chamomile bound to the benzodiazepine site on brain receptors, with a Ki of 4 microM [3]. In mice it reduced anxiety-like behavior without sedation, and a 10-fold increase in dosage produced a mild sedative effect [3]. A 2026 mouse study found that apigenin combined with magnesium lengthened sleep by 44% in normal mice, more than either alone [18]. These are animal findings and do not show an effect in people.
A 2024 review written by two full-time employees of Tally Health, which paid the publication fee, describes a CD38 and NAD+ mechanism in mice [13]. The same review points to human clinical studies using chamomile extract, which contains apigenin, as support for apigenin's potential [13].
Absorption matters for any supplement claim. In healthy men, apigenin taken on its own was poorly absorbed, with metabolites equal to 0.5% of the intake excreted in urine over 24 hours [4]. Apigenin glycosides from chamomile tea were absorbed better, peaking at about 2 h with 34% of the intake excreted, and a parsley drink peaked at 4 h with 11.2% excreted [4]. A separate parsley feeding trial in 14 adults recovered 0.58% of apigenin intake in urine [14]. A pharmacokinetic review concludes that absorption and bioavailability limit apigenin taken by mouth [1].
Safety and interactions
Safety flag. A systematic review of 72 chamomile trials recorded 65 adverse events across 10 trials, mostly self-limiting gastrointestinal complaints and drowsiness [17]. Six of 11 case reports described allergic reactions, three of them anaphylactic [17]. NCCIH and a 2006 review say allergic reactions are more likely in people allergic to daisy-family plants such as ragweed [20][2]. Data on pregnancy and breastfeeding are insufficient [17][20]. LiverTox says chamomile has not been convincingly linked to clinically apparent liver injury (likelihood score E, unlikely) [26].
Who sources say should be careful.
- People allergic to plants in the daisy family, such as ragweed, chrysanthemums, marigolds or daisies, are more likely to react to chamomile, according to NCCIH and a 2006 review [20][2].
- Pregnant and breastfeeding people: NCCIH says little is known about safety, and the 2025 review found insufficient data [20][17].
- People with conditions sensitive to estrogen: NCCIH says chamomile might worsen them [20].
- Drivers and machine operators: Health Canada requires a drowsiness caution on chamomile products [24].
A 2025 systematic review of 72 trials and 11 case reports found that, among 2,896 people given chamomile, 65 adverse events were reported across 10 trials [17]. The most common were gastrointestinal complaints and drowsiness, which were self-limiting and not serious [17]. Reporting was incomplete, and 28 trials gave no adverse event data [17]. In the 2024 sleep review, no adverse events were reported, though most trials relied on passive surveillance [5].
Allergy is the reaction sources single out. Six of the 11 case reports in the 2025 review described allergic reactions, three of them anaphylactic [17]. NCCIH lists nausea, dizziness and allergic reactions, including anaphylaxis, as uncommon side effects [20]. Health Canada requires chamomile products to tell users to stop if hypersensitivity or allergy occurs, and to warn about drowsiness when driving or using machinery [24].
NCCIH says chamomile is likely safe in amounts found in teas and foods and possibly safe for short-term medicinal use by mouth [20]. LiverTox, the NIH liver injury database, says chamomile has not been convincingly linked to clinically apparent liver injury and rates it an unlikely cause [26]. It also says chamomile might have some effects like estrogen [20]. In trials, adverse events were similar with chamomile and placebo in the insomnia pilot [7], the 8-week anxiety trial [10] and the 26-week continuation trial [11]. The insomnia pilot and the 26-week trial used products provided by MediHerb and the Swedish Herbal Institute [7][11].
We found no human safety data for isolated apigenin supplements. In a food study, 18 healthy volunteers ate 5 g of dried parsley a day (84 mg of apigenin) for 7 days, with no significant effect on platelet aggregation or other clotting measures [15]. In the 2-week combination trial funded by Momentous LLC, the only possibly product-related adverse events, in 2 people, were in the morning-blend group, which did not take apigenin [19]. A review of apigenin pharmacokinetics says its drug interactions need more research [1].
Interactions sources report
Warfarin is a blood thinner with a narrow safe range. NCCIH reports that interactions between chamomile and warfarin have been reported, as have interactions with some drugs metabolized by the liver [20]. It adds that there are theoretical reasons to suspect interactions with sedatives [20]. NCCIH also says preliminary studies suggest chamomile might reduce the effect of birth control pills [20].
One small trial tested clotting directly. In 12 healthy volunteers not taking anticoagulants, 7 days of chamomile tea (9 bags a day) or chamomile extract capsules did not prolong prothrombin time compared with placebo [16]. The authors note that the bleeding precaution rests largely on one case report, and their result applies to people not taking warfarin [16]. The trial was funded by a university anesthesiology department [16]. In laboratory tests, apigenin inhibited platelet clumping only at concentrations far above those reached in the body [15].
If you take any of these medicines, talk to your doctor or pharmacist before combining them with apigenin or chamomile.
Regulatory status
| Market | Status | Notes |
|---|---|---|
| US | Not verified as of November 12, 2026 whether FDA has a statement specific to apigenin (the fda.gov site search returned an error). NCCIH notes that dietary supplements are not approved by FDA before they are sold; under DSHEA, firms are responsible for safety and labeling. German (Hungarian) chamomile is listed in 21 CFR 182.10 and 182.20 as generally recognized as safe for its intended use as a seasoning, flavoring or natural extractive. | |
| UK | Not verified as of November 11, 2026. We checked the GOV.UK search API for apigenin (two Committee on Toxicity pages, neither stating a legal status) and could not confirm the status of apigenin or chamomile supplements. | |
| Canada | German chamomile (oral) has a Health Canada natural health product monograph dated December 19, 2025, with a traditional-use claim for restlessness and/or nervousness (which helps to promote sleep) and an adult range of 1.5-24.0 g of chamomile dried flower a day across its preparations. Not verified for isolated apigenin: no apigenin monograph in the monograph list, and the ingredient search returned an error. | |
| Australia | Not verified as of November 11, 2026. A search of tga.gov.au for apigenin returned no matching results, and a chamomile search timed out, so we could not confirm the status of apigenin or chamomile products. | |
| EU | The European Medicines Agency's herbal committee (HMPC) has a finalized EU herbal monograph for chamomile flower (Matricariae flos) based on traditional use for minor gastrointestinal complaints, common cold symptoms and minor mouth, throat and skin complaints. Not verified for isolated apigenin as of November 11, 2026 (EU Novel Food Catalogue not checked; it needs JavaScript). |
FAQ
Is there research on apigenin supplements for sleep?
As of November 11, 2026, we found no randomized trials of isolated apigenin on sleep in people (PubMed and Europe PMC search, 2026-11-11). The human sleep trials used chamomile extract or tea, and a 2024 review written by employees of the company Tally Health points to human clinical studies using chamomile extract, which contains apigenin [13].
How much apigenin did chamomile studies use?
One insomnia trial gave 270 mg of chamomile extract twice daily, and the trial reported 3.9 mg of apigenin per 90 mg of that extract [7]. Other trials used extracts standardized to 1.2% apigenin [10][16]. These are study doses, not advice.
Is chamomile tea the same as an apigenin supplement?
No. Chamomile flowers contain apigenin along with quercetin, luteolin and other compounds [2]. In healthy men, apigenin from chamomile tea was absorbed far better than apigenin taken on its own, with 34% versus 0.5% of the intake recovered in urine [4].
Does chamomile affect blood clotting?
In a crossover trial of 12 healthy volunteers not taking warfarin, 7 days of chamomile tea or extract did not prolong prothrombin time [16]. NCCIH still says interactions between chamomile and warfarin have been reported [20].
References
- Tang D, Chen K, Huang L, et al. Pharmacokinetic properties and drug interactions of apigenin, a natural flavone. Expert Opin Drug Metab Toxicol. 2017.
- McKay DL, Blumberg JB. A review of the bioactivity and potential health benefits of chamomile tea (Matricaria recutita L.). Phytother Res. 2006.
- Viola H, Wasowski C, Levi de Stein M, et al. Apigenin, a component of Matricaria recutita flowers, is a central benzodiazepine receptors-ligand with anxiolytic effects. Planta Med. 1995.
- Borges G, Fong RY, Ensunsa JL, et al. Absorption, distribution, metabolism and excretion of apigenin and its glycosides in healthy male adults. Free Radic Biol Med. 2022.
- Kazemi A, Shojaei-Zarghani S, Eskandarzadeh P, et al. Effects of chamomile (Matricaria chamomilla L.) on sleep: A systematic review and meta-analysis of clinical trials. Complement Ther Med. 2024.
- Hieu TH, Dibas M, Surya Dila KA, et al. Therapeutic efficacy and safety of chamomile for state anxiety, generalized anxiety disorder, insomnia, and sleep quality: A systematic review and meta-analysis of randomized trials and quasi-randomized trials. Phytother Res. 2019.
- Zick SM, Wright BD, Sen A, et al. Preliminary examination of the efficacy and safety of a standardized chamomile extract for chronic primary insomnia: a randomized placebo-controlled pilot study. BMC Complement Altern Med. 2011.
- Adib-Hajbaghery M, Mousavi SN. The effects of chamomile extract on sleep quality among elderly people: A clinical trial. Complement Ther Med. 2017.
- Chang SM, Chen CH. Effects of an intervention with drinking chamomile tea on sleep quality and depression in sleep disturbed postnatal women: a randomized controlled trial. J Adv Nurs. 2016.
- Amsterdam JD, Li Y, Soeller I, et al. A randomized, double-blind, placebo-controlled trial of oral Matricaria recutita (chamomile) extract therapy for generalized anxiety disorder. J Clin Psychopharmacol. 2009.
- Mao JJ, Xie SX, Keefe JR, et al. Long-term chamomile (Matricaria chamomilla L.) treatment for generalized anxiety disorder: A randomized clinical trial. Phytomedicine. 2016.
- Saadatmand S, Zohroudi F, Tangestani H. The Effect of Oral Chamomile on Anxiety: A Systematic Review of Clinical Trials. Clin Nutr Res. 2024.
- Kramer DJ, Johnson AA. Apigenin: a natural molecule at the intersection of sleep and aging. Front Nutr. 2024.
- Nielsen SE, Young JF, Daneshvar B, et al. Effect of parsley (Petroselinum crispum) intake on urinary apigenin excretion, blood antioxidant enzymes and biomarkers for oxidative stress in human subjects. Br J Nutr. 1999.
- Janssen K, Mensink RP, Cox FJ, et al. Effects of the flavonoids quercetin and apigenin on hemostasis in healthy volunteers: results from an in vitro and a dietary supplement study. Am J Clin Nutr. 1998.
- Schwartz JA, Romeiser JL, Kimura R, et al. Effect of chamomile intake on blood coagulation tests in healthy volunteers: a randomized, placebo-controlled, crossover trial. Perioper Med (Lond). 2023.
- Ostovar M, Rezaee Z, Najibi SM, et al. Chamomile: A systematic review of adverse events. Complement Ther Med. 2025.
- Wong WY, Chan BD, Zhou H, et al. Synergistic sleep-promoting effects of magnesium and apigenin in normal and insomnia mouse models. Food Funct. 2026.
- Mastrofini GF, Romersi RF, Lombardi MG, et al. Modulating stress and sleep through a multi-compound dietary supplement: a randomized, double-blind, placebo-controlled trial. J Int Soc Sports Nutr. 2026.
- National Center for Complementary and Integrative Health (NIH). Chamomile. November 2024.
- U.S. Food and Drug Administration. Dietary Supplements. Updated October 1, 2024.
- Electronic Code of Federal Regulations (eCFR). 21 CFR 182.10 Spices and other natural seasonings and flavorings. eCFR up to date as of 2026-11-09.
- Electronic Code of Federal Regulations (eCFR). 21 CFR 182.20 Essential oils, oleoresins (solvent-free), and natural extractives (including distillates). eCFR up to date as of 2026-11-09.
- Health Canada, Natural and Non-prescription Health Products Directorate. Natural Health Products Ingredients Database monograph: Chamomile, German - Oral. Updated December 19, 2025.
- European Medicines Agency, Committee on Herbal Medicinal Products (HMPC). Matricariae flos - herbal medicinal product. Summary for the public last updated 2016-04-05.
- LiverTox, National Institute of Diabetes and Digestive and Kidney Diseases (NIH). Chamomile. Updated May 24, 2022.